1-(苯磺酰基)-5-甲氧基吲哚 | 56995-12-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(苯磺酰基)-5-甲氧基吲哚
• 英文名称: 1-benzenesulfonyl-5-methoxy-1H-indole
• 英文别名: 5-methoxy-1-phenylsulfonyl-1H-indole；5-methoxy-1-(phenylsulfonyl)indole；1-benzenesulfonyl 5-methoxy indole；1-(phenylsulfonyl)-5-methoxyindole；N-(phenylsulfonyl)-5-methoxyindole；5-methoxy-1-(phenylsulfonyl)-1H-indole；1-(benzenesulfonyl)-5-methoxyindole
• CAS: 56995-12-1
• 化学式: C₁₅H₁₃NO₃S
• mdl: MFCD08073380
• 分子量: 287.339
• InChiKey: LAGWFKSQVPRITG-UHFFFAOYSA-N

物化性质

• 熔点：
  97-98 °C
• 沸点：
  483.9±37.0 °C(Predicted)
• 密度：
  1.27±0.1 g/cm3(Predicted)
• 溶解度：
  1.6 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  56.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(苯磺酰基)-5-甲氧基吲哚 在 正丁基锂 、 四丁基氟化铵 、 二异丙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 0.5h， 生成 (5-甲氧基-1H-吲哚-2-基)苯基甲酮
  参考文献：
  名称：

  Bis(1H-2-indolyl)methanones as a Novel Class of Inhibitors of the Platelet-Derived Growth Factor Receptor Kinase

  摘要：

  The novel lead bis(1H-2-indolyl)methanone inhibits autophosphorylation of platelet-derived growth factor (PDGF) receptor tyrosine kinase in intact cells. Various substituents in the 5- or 6-position of one indole ring increase or preserve potency, whereas most modifications of the ring structures and of the methanone group as well as substitution at both indoles result in weak or no activity. An ATP binding site model, derived by homology from the FGFR-1 tyrosine kinase crystal structure suggesting hydrogen bonds of one indole NH and the methanone oxygen with the backbone carbonyl and amide, respectively, of Cys684, explains why only one indole moiety is open for substitution and locates groups in the 5- or 6-position outside the pocket. The hitherto most active derivatives, 39, 53 and 67, inhibit both isoforms of the PDGF receptor kinase in intact cells, with IC50 of 0.1-0.3 muM, and purified PDGFbeta-receptor in vitro, with IC50 of 0.09, 0.1, or 0.02 muM, respectively. PDGF-stimulated DNA synthesis is inhibited by these derivatives with IC50 values of 1-3 muM. Kinetic analysis of 53 showed an ATP-competitive mode of inhibition. The compounds are inactive or weakly active toward a number of other tyrosine kinases, including the FGF receptor 1, EGF receptor, and c-Src kinase, as well as toward serine-threonine kinases, including different PKC isoforms and GRK2, and appear therefore selective for PDGF receptor inhibition.

  DOI：

  10.1021/jm010988n
• 作为产物：
  描述：

  4-硝基间甲苯酚 在 palladium on activated charcoal 正丁基锂 、 氢气 、 sodium methylate 作用下， 以 N,N-二甲基甲酰胺 、 苯 为溶剂， -75.0~25.0 ℃ 、303.98 kPa 条件下， 反应 50.0h， 生成 1-(苯磺酰基)-5-甲氧基吲哚
  参考文献：
  名称：

  A versatile and efficient construction of the 6H-pyrido[4,3-b]carbazole ring system. Syntheses of the antitumor alkaloids ellipticine, 9-methoxyellipticine, and olivacine, and their analogs

  摘要：

  A general and efficient synthesis of the 6H-pyrido[4,3-b]carbazole ring system is described, in which the key steps are (1) regioselective acylation of a 2-lithio-1-(phenylsulfonyl)indole (14) with 3,4-pyridinedicarboxylic acid anhydride (10), (2) cyclization of the deprotected keto acid 17 to keto lactam 19 with acetic anhydride, and (3) the addition of methyllithium to give, after reduction of the intermediate diol 23 with sodium borohydride, the target ring system. In this fashion, ellipticine (1a), 9-methoxyellipticine (1b), and 9-hydroxyellipticine (1c) were synthesized in excellent overall yields from indole. The use of Superhydride, in place of 1 equiv of methyllithium, provided a synthesis of olivacine (2), and the use of phthalic anhydride in the sequence allowed for the preparation of 6,11-dimethylbenzo[b]carbazole (48). The overall yields of ellipticine (1a) (54%) and 9-methoxyellipticine (1b) (47%) in six steps from their respective indoles represent one of the most efficient syntheses of these antitumor alkaloids.

  DOI：

  10.1021/jo00048a022

文献信息

• Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators
  作者：Iain R. Greig、Gemma L. Baillie、Mostafa Abdelrahman、Laurent Trembleau、Ruth A. Ross

  DOI：10.1016/j.bmcl.2016.08.018

  日期：2016.9

  CB1-mediated effects. Thus, a greater range of molecular tools are required to allow definitive elucidation of the effects of CB1 allosteric modulation. In this study, we show a novel series of indole sulfonamides. Compounds 5e and 6c (ABD1075) had potencies of 4 and 3nM respectively, and showed good oral exposure and CNS penetration, making them highly versatile tools for investigating the therapeutic

  现有的CB1阴性变构调节剂（NAM）属于结构类别的有限范围。尽管具有CB1 NAM的理论潜力，但已发表的体内研究通常不能证明预期的与治疗相关的CB1介导的作用。因此，需要更大范围的分子工具才能明确阐明CB1变构调节作用。在这项研究中，我们显示了一系列新颖的吲哚磺酰胺。化合物5e和6c（ABD1075）的效力分别为4和3nM，并显示出良好的口服暴露和CNS渗透性，使其成为研究大麻素系统的变构调节作用的潜在治疗工具。
• Process for the preparation of isoquinoline derivatives
  申请人：Sanofi

  公开号：US05079363A1

  公开（公告）日：1992-01-07

  The subject of the present invention is a process for the preparation of isoquinoline derivatives in four steps wherein use is made as synthetic intermediates of organo-lithium compounds or related compounds.

  本发明的主题是一种四步法制备异喹啉衍生物的过程，其中使用有机锂化合物或相关化合物作为合成中间体。
• 2-Aminoimidazole-based antagonists of the 5-HT6 receptor – A new concept in aminergic GPCR ligand design
  作者：Adam S. Hogendorf、Agata Hogendorf、Rafał Kurczab、Justyna Kalinowska-Tłuścik、Piotr Popik、Agnieszka Nikiforuk、Martyna Krawczyk、Grzegorz Satała、Tomasz Lenda、Joanna Knutelska、Ryszard Bugno、Jakub Staroń、Wojciech Pietruś、Mikołaj Matłoka、Krzysztof Dubiel、Rafał Moszczyński-Pętkowski、Jerzy Pieczykolan、Maciej Wieczorek、Bogusław Pilarski、Paweł Zajdel、Andrzej J. Bojarski

  DOI：10.1016/j.ejmech.2019.06.001

  日期：2019.10

  molecular switch may be responsible for the observed differences in 5-HT6R activity of the studied chemotypes with different amine-like fragments. Considering the multiple functionalization sites of the embedded guanidine fragment, diverse libraries were constructed, and the relationships between the structure and activity, metabolic stability, and solubility were established. Compounds from the N

  提出了一种设计胺能GPCR配体的新策略–使用芳族，杂环碱性部分代替常绿哌嗪或脂环族和脂肪族胺。该假设已通过使用一系列基准的5-HT 6 R拮抗剂进行了测试，这些拮抗剂是通过将各种取代的2-氨基咪唑基团偶联至完善的1-苯磺酰基-1 H-吲哚（用作配体核心）而获得的。晶体学研究表明，质子化后，2-氨基咪唑片段触发共振驱动的构象变化，从而导致更高的亲和力。这种分子转换可能是造成5-HT 6差异的原因具有不同胺样片段的化学型的R活性。考虑到嵌入的胍片段的多个功能化位点，构建了各种文库，并建立了结构与活性，代谢稳定性和溶解度之间的关系。N-（1 H-咪唑-2-基）酰基酰胺化学型（10a – z）的化合物对5-HT 6 R表现出高亲和力，对5-HT 1A，5-HT 2A，5-HT 7的选择性很高和D 2受体（结合可忽略不计），这归因于其非常弱的碱性。已显示4-甲基-5- [1-（萘-1-磺酰基）-1 H-吲哚-3-基]
• Regioselective Direct C3-Phosphorylation of<i>N</i>-Sulfonylindoles under Mild Oxidative Conditions
  作者：Feng Su、Weidong Lin、Pengfei Zhu、Dezhi He、Jianbin Lin、Hui-Jun Zhang、Ting-Bin Wen

  DOI：10.1002/adsc.201601204

  日期：2017.3.20

  The reactions of N‐sulfonylindoles with H‐phosphine oxides under oxidative conditions give a wide range of C‐3 phosphorylated free (NH)‐indoles. Several mild oxidants, such as AgNO3, di‐tert‐butyl peroxide (DTBP), and K2S2O8, can be used to promote this transformation.

  在氧化条件下，N-磺酰吲哚与H-氧化膦的反应产生了多种C-3磷酸化的游离（NH）-吲哚。可以使用几种弱氧化剂，例如AgNO 3，过氧化二叔丁基（DTBP）和K 2 S 2 O 8来促进这种转化。
• [EN] MAP4K4 (HGK) Inhibitors<br/>[FR] INHIBITEURS DE MAP4K4 (HGK)
  申请人：STANFORD RES INST INT

  公开号：WO2016114816A1

  公开（公告）日：2016-07-21

  The invention provides mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) inhibitors, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant diminution of tumor cell growth, cancer or metastasis.

  该发明提供了有丝分裂原激活蛋白激酶激酶激酶激酶4（MAP4K4）抑制剂，以及其药用盐、氢化物和立体异构体。这些化合物被用于制备药物组合物，并用于制备方法，包括使用有效量的该化合物或组合物治疗需要的人，以及检测结果肿瘤细胞生长、癌症或转移的减少。